drugset / Trial / NCT05979727
Dose-finding PKPD Trial for RE02 in Healthy Subjects
RandomizedCrossoverTriple-blindOther
Summary
The goal of this clinical trial is to compare corresponding inter- and intraindividual pharmacokinetic and pharmacodynamic profiles including assessments of safety \& tolerability of three different doses against a placebo control.
Timeline
- Start
- 2023-11-20
- Primary completion
- 2023-12-10
- Completion
- 2023-12-10
Outcome
Outcome not reported
Stopped: “The trial was closed due to futility”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | RE02 | Unknown | — | — |
Indications
No indication recorded.